Testicular cancer is a type of cancer that develops in the cells of the testicles, which are the male reproductive glands that produce sperm and hormones. It is a relatively rare form of cancer, but it is the most common cancer in young people with testicles aged 15 to 35 years. The exact cause of testicular cancer is unknown, but certain risk factors have been identified, including having a family history of the disease, having an undescended testicle, having a personal history of testicular cancer, and having abnormal testicular development. Symptoms of testicular cancer may include a lump or swelling in one or both testicles, pain or discomfort in the testicles or scrotum, a feeling of heaviness in the scrotum, and enlargement or tenderness of the breasts. Testicular cancer is usually diagnosed through a physical exam, imaging tests such as ultrasound, and blood tests to check for tumour markers. Treatment for testicular cancer typically involves surgery to remove the affected testicle, followed by radiation therapy, chemotherapy, or a combination of these, depending on the stage and type of cancer. You can find out which of our Healthcare Providers have expertise in this area on our Workstreams & Expertise page. We recommend the EAU Guidelines on testicular cancer, which you can access from our guidelines page: ERN eUROGEN has developed patient information on testicular cancer, which is available from our patient information page.Testicular Cancer (ERN eUROGEN EA 3.2)
Expertise Area Coordinator: Arnout Alberts
Vice-EAC: vacant
Guidelines
Patient Information
